SCHEMBL11296058

SCHEMBL11296058

COC(=O)c1ccc(N(c2ccccc2)C2CCNC2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ TSHR P16473 2/20 0.44
▸ MAPT P10636 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ ROCK2 O75116 1/20 0.41
▸ L3MBTL1 Q9Y468 4/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ OPRD1 P41143 3/20 0.40
▸ OPRM1 P35372 2/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11295039 0.89 PSEN1 (0.40) KMT2ATSHRSMN1; SMN2GAA
SCHEMBL11296532 0.88 SLC6A3 (0.40) MEN1KMT2ATSHRMAPTRAB9A
SCHEMBL11299441 0.85 MAPK14 (0.37) MEN1KMT2ATSHRMAPTL3MBTL1
SCHEMBL11296506 0.84 ALOX15 (0.44) TSHRRAB9AL3MBTL1ALDH1A1HTT
SCHEMBL11301393 0.83 ALOX15 (0.56) MEN1KMT2AMAPTRAB9AOPRD1
SCHEMBL11301136 0.80 ROCK2 (0.42) MEN1KMT2ATSHRMAPTRAB9A
SCHEMBL11301119 0.80 MAPT (0.40) MEN1KMT2ATSHRMAPTRAB9A
SCHEMBL11296615 0.80 FLT1 (0.38) MEN1KMT2AMAPTRAB9ACASP3
SCHEMBL11297519 0.78 HDAC6 (0.43) RAB9AALDH1A1SMN1; SMN2HTTPOLB
SCHEMBL11297424 0.77 HDAC1 (0.43) MAPTRAB9AOPRD1OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback